We are live on ! Find out more
SA

Sovran Advisors Portfolio holdings

AUM $1.34B
1-Year Est. Return 21.63%
This Fund
S&P 500
This Quarter Est. Return
+1.28%
1 Year Est. Return
+21.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
+$45.3M
Cap. Flow
+$31.6M
Cap. Flow %
2.69%
Top 10 Hldgs %
18.09%
Holding
582
New
63
Increased
234
Reduced
235
Closed
31
Avg Time Held
2.9 quarters
Top 10 Avg Time Held
2.9 quarters
Top 20 Avg Time Held
2.9 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 71.4%
2 Technology 11.45%
3 Financials 4.01%
4 Communication Services 3.03%
5 Consumer Discretionary 2.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ELV icon
501
Elevance Health
ELV
$92.2B
$232K 0.02%
+608
New +$205K
2025 Q4
0 quarters
USXF icon
502
iShares ESG Advanced MSCI USA ETF
USXF
$1.47B
$232K 0.02%
3,930
-735
-16% -$42.3K
2025 Q1
3 quarters
SLYG icon
503
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$4.79B
$230K 0.02%
2,282
-222
-9% -$21K
2025 Q2
2 quarters
AZN icon
504
AstraZeneca
AZN
$242B
$229K 0.02%
+1,220
New +$214K
2025 Q4
0 quarters
IDHQ icon
505
Invesco S&P International Developed Quality ETF
IDHQ
$1.12B
$227K 0.02%
6,151
-584
-9% -$20.2K
2025 Q2
2 quarters
VTEB icon
506
Vanguard Tax-Exempt Bond Index Fund
VTEB
$50B
$226K 0.02%
4,468
-144
-3% -$7.25K
2025 Q3
1 quarter
HEDJ icon
507
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.74B
$226K 0.02%
+4,099
New +$213K
2025 Q4
0 quarters
RWL icon
508
Invesco S&P 500 Revenue ETF
RWL
$10.1B
$226K 0.02%
1,902
-193
-9% -$21.7K
2025 Q1
3 quarters
ENB icon
509
Enbridge
ENB
$106B
$226K 0.02%
4,820
-127
-3% -$6.06K
2025 Q3
1 quarter
STRK icon
510
Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock
STRK
$552M
$225K 0.02%
2,579
-836
-24% -$72K
2025 Q3
1 quarter
XRPC icon
511
Canary XRP ETF
XRPC
$317M
$224K 0.02%
+10,200
New +$221K
2025 Q4
0 quarters
UBER icon
512
Uber
UBER
$146B
$222K 0.02%
2,634
+75
+3% +$6.75K
2025 Q2
2 quarters
KKR icon
513
KKR & Co
KKR
$78.2B
$222K 0.02%
+1,690
New +$210K
2025 Q4
0 quarters
PEG icon
514
Public Service Enterprise Group
PEG
$35.1B
$220K 0.02%
2,771
+97
+4% +$7.91K
2025 Q3
1 quarter
CMCSA icon
515
Comcast
CMCSA
$74.1B
$220K 0.02%
+7,751
New +$221K
2025 Q4
0 quarters
URTH icon
516
iShares MSCI World ETF
URTH
$8.3B
$220K 0.02%
+1,160
New +$213K
2025 Q4
0 quarters
MNST icon
517
Monster Beverage
MNST
$84.8B
$219K 0.02%
5,630
-11,336
-67% -$406K
2025 Q2
2 quarters
WFC icon
518
Wells Fargo
WFC
$244B
$219K 0.02%
+2,459
New +$213K
2025 Q4
0 quarters
FXL icon
519
First Trust Technology AlphaDEX Fund
FXL
$2.89B
$218K 0.02%
1,249
– –
2025 Q2
2 quarters
IYT icon
520
iShares US Transportation ETF
IYT
$1.95B
$218K 0.02%
2,784
-222
-7% -$16.1K
2024 Q4
4 quarters
JNK icon
521
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$5.84B
$217K 0.02%
2,222
– –
2024 Q4
4 quarters
GPC icon
522
Genuine Parts
GPC
$18B
$217K 0.02%
1,593
-52
-3% -$6.73K
2025 Q1
3 quarters
PPG icon
523
PPG Industries
PPG
$23.2B
$216K 0.02%
+1,962
New +$197K
2025 Q4
0 quarters
CNQ icon
524
Canadian Natural Resources
CNQ
$107B
$214K 0.02%
+6,288
New +$204K
2025 Q4
0 quarters
IBB icon
525
iShares Biotechnology ETF
IBB
$10.2B
$214K 0.02%
+1,253
New +$204K
2025 Q4
0 quarters

Similar funds

Sovran Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Sovran Advisors held 582 positions worth $1.18B, up 4% from $1.13B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Sovran Advisors's Q4 2025 filing shows 63 new, 234 increased, 235 reduced and 31 closed positions. Its largest new stake was CoreWeave: 70,438 shares worth $6.69M. The largest sale was Ionis Pharmaceuticals, an estimated $11.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, down from 72% a quarter earlier, followed by Technology and Financials.

  • Sovran Advisors's largest Q4 2025 buy was CoreWeave: 70,438 shares worth $6.69M.
  • Sovran Advisors added most to Broadcom in Q4 2025, an estimated $6M increase.
  • Sovran Advisors's biggest Q4 2025 reduction was PIMCO RAFI Multi-Factor International Equity ETF, cutting an estimated $4.07M.
  • Sovran Advisors fully exited Ionis Pharmaceuticals in Q4 2025, selling an estimated $11.2M.
  • Sovran Advisors's ten largest holdings make up 18% of its $1.18B portfolio in Q4 2025.
  • Sovran Advisors opened 63 new positions and closed 31 in Q4 2025.
  • Sovran Advisors's portfolio value rose 4% quarter-over-quarter to $1.18B.

Based on Sovran Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.